Oligodendrocytes are myelin forming cells in mammalian central nervous syst
em. About 50% of oligodendrocytes (OLGs) undergo cell death in normal devel
opment. In addition, OLG cell deaths have been observed in demyelinating di
seases including multiple sclerosis (MS). Clinical observations and in vitr
o cell culture studies have suggested that cytokines mediate OLG cell damag
e in multiple sclerosis (MS). Among the cytokines, tumor necrosis factor (T
NF) is thought to be one of the mediators responsible for the damage of OLG
s in MS. The administration of TNF-alpha to primary cultures of OLGs induce
d DNA fragmentation, and significantly decreased the number of live OLGs. C
hemical inhibitors Ac-YVAD-CHO (a specific inhibitor of caspase-1 (ICE)-lik
e proteases) enhanced the survival of TNF-alpha treated OLGs better than Ac
-DEVD-CHO (a specific inhibitor of caspase-3 (CPP32)-like proteases). These
results indicate that caspase-1-mediated cell-death pathway are activated
in TNF-induced OLG cell death. Caspase-11 is involved in activation of casp
ase-1. Oligodendrocytes from caspase-11-deficient mice are partially resist
ant to TNF-induced OLG cell death. Our results suggest that the inhibition
of caspase-1 sufamily may be a novel therapeutic approach to treat MS.